LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

LLY

1,027.65

+0.36%↑

JNJ

199.6

+1.83%↑

ABBV

234.59

+0.96%↑

UNH

326.36

+1.55%↑

AZN

89.88

+0.83%↑

Начало・Списък с акции・Avita Therapeutics Inc

Avita Therapeutics Inc

Отворен

3.76 1.08

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

3.62

Максимум

3.86

Ключови измерители
By Trading Economics
Приходи	3.9M -9.9M
Продажби	-96K 18M
EPS	-0.712
Марж на печалбата	-53.86
Служители	260
EBITDA	4M -8.1M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+94.67% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-20M 121M
Предишно отваряне	2.68
Предишно затваряне	3.76

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

8.83 / 9.77 Подкрепа & съпротива

Avita Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.11.2025 г., 17:45 ч. UTC

Печалби

Значими двигатели на пазара

Figure Technology Shares Rise After Higher 3Q Earnings, Revenue

14.11.2025 г., 17:31 ч. UTC

Печалби

Значими двигатели на пазара

American Bitcoin Advances on 3Q Profit, Eric Trump's Crypto Confidence

16.11.2025 г., 23:40 ч. UTC

Пазарно говорене

Gold Rises on Likely Technical Recovery -- Market Talk

16.11.2025 г., 23:36 ч. UTC

Пазарно говорене

Nikkei May Edge Lower Amid Lingering Worries Over Elevated Tech Valuations -- Market Talk

16.11.2025 г., 23:26 ч. UTC

Пазарно говорене

RBA Policy Meetings May Contain a Trap for Traders -- Market Talk

16.11.2025 г., 16:20 ч. UTC

Печалби

Fed Minutes, Plus Walmart, Target, Home Depot, Nvidia, and More Stocks to Watch This Week -- Barrons.com

15.11.2025 г., 09:20 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

15.11.2025 г., 09:20 ч. UTC

Пазарно говорене

Energy & Utilities Roundup: Market Talk

15.11.2025 г., 00:08 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 3rd Update

14.11.2025 г., 23:56 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Hathaway Bought Alphabet Shares Worth $4.3 Billion in the Third Quarter. Here's What It Sold. -- Barrons.com

14.11.2025 г., 23:02 ч. UTC

Пазарно говорене

Chinese Battery Makers Benefit From U.S. Rising Demand -- Market Talk

14.11.2025 г., 22:35 ч. UTC

Печалби

Придобивния, сливания и поглъщания

The Score: Tyson, Robinhood, Walmart, Paramount Skydance and More Stocks That Defined the Week -- WSJ

14.11.2025 г., 22:32 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- 2nd Update

14.11.2025 г., 22:29 ч. UTC

Печалби

Starbucks Scores on Holiday Sales. It's a Good Sign for the Turnaround. -- Barrons.com

14.11.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Further Pares Apple Stake -- Update

14.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

14.11.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Buys Shares of Alphabet and Pares Apple Stake -- WSJ

14.11.2025 г., 20:27 ч. UTC

Пазарно говорене

Oil Futures Rise After Ukraine Strikes Russian Port -- Market Talk

14.11.2025 г., 20:23 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Post Weekly Gain -- Market Talk

14.11.2025 г., 20:17 ч. UTC

Придобивния, сливания и поглъщания

Several State Attorneys General Oppose Railroad Merger -- WSJ

14.11.2025 г., 19:29 ч. UTC

Пазарно говорене

Печалби

Applied Materials' F4Q Results Seen as 'Uninspiring' -- Market Talk

14.11.2025 г., 18:44 ч. UTC

Пазарно говорене

Печалби

Disney's Growth Now Hinges More on ESPN -- Market Talk

14.11.2025 г., 18:27 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

14.11.2025 г., 18:27 ч. UTC

Пазарно говорене

Morgan Stanley Sees 'Worthy Successor' in Walmart CEO Furner -- Market Talk

14.11.2025 г., 18:20 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises by 3 to 417 -- Market Talk

14.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Печалби

Auto & Transport Roundup: Market Talk

14.11.2025 г., 17:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

14.11.2025 г., 17:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

14.11.2025 г., 16:51 ч. UTC

Пазарно говорене

Starbucks Gets Holiday Sales Lift -- Market Talk

14.11.2025 г., 16:48 ч. UTC

Пазарно говорене

Gold Slides Amid Selloff, Lower December Fed Rate-Cut Expectations -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Avita Therapeutics Inc Прогноза

Ценова цел

By TipRanks

94.67% нагоре

12-месечна прогноза

Среден 7.3 USD 94.67%

Висок 14 USD

Нисък 3 USD

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Avita Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

5 ratings

Купи

Задържане

Продай

Според 5 анализатори, дали борсови рейтинги на Avita Therapeutics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

8.83 / 9.77Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.